CLP 1601.2
(-0.51%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 463.55 Million | 231.31 Million | 28.78 Million | 17.96 Million | 12.05 Million |
Net Income | -10.35 Million | 86.76 Million | 560.77 Million | 149.32 Million | -34.72 Million |
Depreciation & Amortization | 338.12 Million | 294 Million | 57.35 Million | 811 Thousand | 684 Thousand |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | - | - | - | - | - |
Other non-cash items | 135.79 Million | -149.45 Million | -589.34 Million | -132.17 Million | 46.1 Million |
Investing Cash Flow | -522.37 Million | -385.88 Million | -173.08 Million | -30.48 Million | -5.7 Million |
Investments in PPE | -516.57 Million | -425.92 Million | -40.67 Million | -3.7 Million | -4.08 Million |
Acquisitions | -9.47 Million | -3.93 Million | -134.28 Million | -26.98 Million | -1.35 Million |
Investment purchases | -5.09 Million | -3.77 Million | -834 Thousand | - | - |
Sales/Maturities of investments | 3.98 Million | 19.03 Million | 44 Thousand | - | - |
Other Investing Activities | -3.77 Million | 19.6 Million | 1.9 Million | 147 Thousand | -268 Thousand |
Financing Cash Flow | 292.95 Million | -443.85 Million | 87.88 Million | 17.12 Million | -8.2 Million |
Debt repayment | -614.62 Million | -163.44 Million | -37.31 Million | -30.02 Million | -1.89 Million |
Dividends payments | -216.11 Million | -554.48 Million | - | -9.27 Million | -3.97 Million |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 278 Thousand | - | - | - | - |
Other Financing Activities | 4.25 Million | 5.86 Million | 59.5 Million | -2.12 Million | -2.33 Million |
Accounts receivables | - | - | - | - | - |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | - | - | - | - | - |
Cash at beginning of period | 272.29 Million | 873.86 Million | 931.3 Million | 3.05 Million | 4.7 Million |
Cash at end of period | 503.64 Million | 272.29 Million | 873.86 Million | 7.76 Million | 3.05 Million |
Capital Expenditure | -516.57 Million | -425.92 Million | -40.67 Million | -3.7 Million | -4.08 Million |
Effect of forex changes on cash | -2.78 Million | -3.15 Million | -1.02 Million | 107 Thousand | -90 Thousand |
Net cash flow / Change in cash | 231.35 Million | -601.57 Million | -57.43 Million | 4.71 Million | -1.64 Million |
Free Cash Flow | -53.01 Million | -194.61 Million | -11.88 Million | 14.25 Million | 7.97 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -137.82 Million | -18.91 Million | -10.35 Million | 65.82 Million | -900 Thousand | -75.16 Million |
Depreciation & Amortization | 106.57 Million | 105.47 Million | 338.12 Million | 94.42 Million | 100.13 Million | 63.43 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 277.71 Million | -3.04 Million | 135.79 Million | 75.37 Million | -32.04 Million | 189.14 Million |
Investing Cash Flow | -130.38 Million | -40.04 Million | -522.37 Million | -139.39 Million | -174.56 Million | -165.43 Million |
Investments in PPE | -96.48 Million | -90.95 Million | -516.57 Million | -116.01 Million | -184.23 Million | -160.44 Million |
Acquisitions | -22.25 Million | -2.68 Million | -9.47 Million | - | -9.47 Million | - |
Investment purchases | - | - | -5.09 Million | - | - | - |
Sales/Maturities of investments | - | 2.05 Million | 3.98 Million | 406 Thousand | 1.73 Million | - |
Other Investing Activities | -17.65 Million | 45.09 Million | -3.77 Million | -26.61 Million | 15.49 Million | -6.93 Million |
Financing Cash Flow | -90.82 Million | -42.33 Million | 292.95 Million | 160.1 Million | 66.81 Million | 5.75 Million |
Debt repayment | -638.04 Million | -8.53 Million | -614.62 Million | -270.79 Million | -774.33 Million | -516.73 Million |
Dividends payments | -12.47 Million | -1.07 Million | -216.11 Million | -82.39 Million | -49.26 Million | -84.46 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 278 Thousand | - | - | - |
Other Financing Activities | 591.12 Million | -536 Thousand | 4.25 Million | 4.72 Million | -631.92 Million | 632.35 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 499.19 Million | 503.64 Million | 272.29 Million | 243.84 Million | 291.71 Million | 274.88 Million |
Cash at end of period | 523.46 Million | 499.19 Million | 503.64 Million | 503.64 Million | 243.84 Million | 291.71 Million |
Capital Expenditure | -96.48 Million | -90.95 Million | -516.57 Million | -116.01 Million | -184.23 Million | -160.44 Million |
Effect of forex changes on cash | -993 Thousand | -5.59 Million | -2.78 Million | 3.46 Million | -7.3 Million | -914 Thousand |
Net cash flow / Change in cash | 24.26 Million | -4.45 Million | 231.35 Million | 259.79 Million | -47.87 Million | 16.83 Million |
Free Cash Flow | 149.97 Million | -7.42 Million | -53.01 Million | 119.6 Million | -117.04 Million | 16.97 Million |
3628
301111
LKFN
RDCPF
CBO
APEX